Conference Recordings

Click or tap on a tab to see the various recordings available for purchase.

No content found

No content found

Preconference Courses

 
Picture of the productISPD 2016: Precon Course 1 - Prenatal Screening

Precon Course 1 - Prenatal Screening in the Era of Cell-free DNA Analysis (half-day): 2 hours, 53 mins

CO-SPONSORED BY ISUOG

A comprehensive introduction to the practice, principles and counselling issues around cell-free DNA for professionals involved in prenatal screening and diagnosis.

Agenda:
The screening test: Understanding detection rate, false-positive rate, positive and negative predictive values, Ann Tabor**
Cell-free DNA testing: Biology, technology and implications for clinical practice, Francesca Grati
Current Down syndrome screening and the place of NIPT, Oliver Kagan
Role of ultrasound in DS screening in the NIPT era, Jon Hyett
cfDNA testing beyond aneuploidies, Sylvie Langlois
Implementation of cell-free DNA testing in clinical practice: An international perspective, Sylvie Langlois
Counselling for aneuploidy screening in the era of cfDNA testing, Lyn Chitty

**NOT SHARED IN THIS RECORDING.


Non-Member price: $230.00
Discounted Member price: $150.00
Quantity    

 View Cart
W_AM16_WS1
Picture of the productISPD 2016: Precon Course 2 - Teratology

Precon Course 2 - Teratology in Pregnancy: How the Mother Affects the Fetus (half-day): 1 hour, 32 mins

Course Objectives:
  • Have a good insight in the changes in maternal pharmacokinetics during pregnancy and lactation.
  • Understand how these pharmacokinetic changes affect transplacental drug transfer and drug transfer in breast milk.
  • Understand the mechanism of action of the most common teratogenic agents and the influence of environment and genetics on these mechanisms.
  • Be able to identify (subclinical) maternal conditions which can potentially harm the fetus, including mild genetic disease and infections.
  • Understand which mechanisms are in place for teratologic event monitoring
  • Understand the methods used in pharmacologic research in pregnancy.
Agenda:
Teratological agents: The impact of environment and genetics, Dick Lindhout**
Clinical pharmacokinetics during pregnancy and lactation, Karel Allegaert
Prescription drugs and pregnancy: Main teratologic agents and surveillance, Maria Hoeltzenbein
Studying pharmacokinetics in pregnancy: What is available?, Kristel Van Calsteren**
Maternal subclinical disease and fetal abnormalities, Ron Wapner**

**NOT SHARED IN THIS RECORDING.


Non-Member price: $230.00
Discounted Member price: $150.00
Quantity    

 View Cart
W_AM16_WS2
Picture of the productISPD 2016: Precon Course 4 - Ultrasound & Genetic Syndromes

Precon Course 4 - Second Trimester Ultrasound and Genetic Syndromes (half-day): 3 hours, 13 mins

Fetal ultrasound can detect many serious structural and chromosomal anomalies, but most single-gene syndromes are not well identified prenatally. This course addresses the prenatal dysmorphology of some groups of genetic syndromes, and outlines management strategies to aid definitive prenatal diagnosis to inform accurate parental counselling.

Agenda:
Cardiac anomalies and genetic syndromes, Rabih Chaoui
Genetic syndromes associated with renal anomalies, Karl Oliver Kagan
Anomalies of the CNS and genetic syndromes, Ignatia Van den Veyver
Limbs anomalies and genetic syndromes, Lyn Chitty
Soft markers and genetic syndromes (not T21), Antoni Borrell


Non-Member price: $230.00
Discounted Member price: $150.00
Quantity    

 View Cart
W_AM16_WS4
Picture of the productISPD 2016: Precon Course 5 - QA for Cell Free DNA

Precon Course 5 - Developing a Quality Assurance Scheme for Cell Free DNA Testing (Co-sponsored by UK NEQAS for Molecular Genetics, EQMN, and CEQAS) (half-day): 1 hour, 54 mins

Course Objectives:
  • To review the current approaches to external quality assessment (EQA) for cell free DNA testing.
  • Learn lessons from the existing EQA schemes.
  • Confirm the way forward for an EQA scheme of NIPT for aneuploidy that would be applicable across the EU and beyond.
  • Outline a potential way forward for NIPD for monogenic disorders as this becomes more widespread
Agenda:
Overview of progress to date for NIPT for aneuploidies EQA scheme, Sandi Deans
Lessons learnt from NIPD for fetal sex determination assessment, Simon Patton**
Trials and tribulations of developing an NIPT (aneuploidy) and NIPD (monogenic disorders) service in an accredited service laboratory in the EU, Lucy Jenkins**
Lessons to be shared when implementing Nipt as part of a national prenatal screening programme, Erik Sistermans**
Developing an EQA system in the USA,Glenn Palomaki
Presentation of draft scheme for discussion/Proposal to draft Best Practice Guidelines for NIPT for aneuploidies, Panel and audience discussion

**NOT SHARED IN THIS RECORDING


Non-Member price: $230.00
Discounted Member price: $150.00
Quantity    

 View Cart
W_AM16_WS5
Picture of the productISPD 2016: Precon Course 6 - Helping Patients Navigate

Precon Course 6 - Shades of Gray: Helping Patients Navigate the Uncertainties that Prenatal Testing Presents (half-day): 3 hours, 21 mins

Prenatal screening and diagnosis may produce uncertain results. Counselors and providers often find these results challenging to interpret and may find it difficult to assist the patient to navigate the remainder of the pregnancy. This course will review the types of uncertainty associated with prenatal testing, and will provide special emphasis on helping patients and their partners through the decision-making process. We will review shared decision-making approaches to help couples who receive abnormal prenatal testing results. Shared decision making is dependent not only on medical facts but also on the patient’s own goals and values. This presentation will increase the participants’ ability to recognize clients experiencing decisional conflict and to identify strategies to assess and address decision making needs. It will provide the opportunity to gain skills in utilizing a tool designed to assist clients with decision making. We encourage all members of the prenatal testing community to attend and share their perspectives.

Course Objective: To help healthcare professionals identify strategies and tools that can be utilized to help their patients who receive an abnormal or uncertain diagnosis.

Agenda:
The pros and cons of prenatal screening and diagnostic techniques utilized in maternal fetal medicine, Jon Hyett
Providing safe independent support to parents after prenatal diagnosis ARC’s perspective, Jane Fisher
Using a shared decision making approach to supporting patients facing uncertain outcomes in the prenatal setting, Susan Berg
Integration of shared decision making techniques in a prenatal setting, Judy Jackson


Non-Member price: $230.00
Discounted Member price: $150.00
Quantity    

 View Cart
W_AM16_WS6

No content found

No content found